医療従事者の為の最新医療ニュースや様々な情報・ツールを提供する医療総合サイト

Granules India to Add 102 Jobs, Invest $35 Million in Fairfax County Pharmaceutical R&D, Manufacturing Operation

2017年05月22日 PM11:30
このエントリーをはてなブックマークに追加


 

FAIRFAX COUNTY, Va.

Governor Terry McAuliffe today announced that Granules India Ltd., a vertically integrated pharmaceutical company, will invest $35 million into its wholly owned subsidiary, Granules Pharmaceuticals Inc., to expand its pharmaceutical R&D and manufacturing capabilities in Fairfax County. Virginia successfully competed against New Jersey for the project, which will create 102 new jobs. In 2014, the company invested $15 million to establish the wholly-owned subsidiary operation, creating 75 jobs.

“The Fairfax County EDA has greatly enjoyed helping Granules India build its presence here. This announcement is important in several ways,” said Gerald L. Gordon, Ph.D., president and CEO of the Fairfax County Economic Development Authority. “The work that Granules India is doing here in pharmaceutical manufacturing and research is a great example of how the life-science industry is growing rapidly here, and the company joins more than 400 other foreign-owned firms that have chosen Fairfax County for U.S. expansion.”

Granules India Ltd. is headquartered in Hyderabad, India. The company manufactures active pharmaceutical ingredients, pharmaceutical formulation intermediates and finished dosages, distributed to customers in regulated and semi-regulated markets. Granules India operates in a 100,000-square foot facility in the Chantilly area of Fairfax County. The company is conducting research and development to formulate products, and intends to manufacture products in the location as well.

“Setting up a development and manufacturing presence in the United States was the first step we took as a company to meet our strategic focus on strengthening our global presence,” said Priyanka Chigurupati, executive vice president, Granules India Ltd. “We are very excited about our plans for expansion in Fairfax County. There is a lot of untapped potential with a highly educated and technically savvy workforce, reliable security, diverse amenities and state-of-the-art infrastructure including Dulles International Airport, the Port of Virginia, and the expanded Metrorail in close proximity.”

The Virginia Economic Development Partnership will support Granules’ new job creation through its Virginia Jobs Investment Program. State-funded VJIP provides consultative services and funding to companies creating new jobs or experiencing technological change to support employee training activities.

Time magazine called Fairfax County “one of the great economic success stories of our time.” Business growth and innovation helps Fairfax County fund the nation’s top-rated school system and other public services that contribute to the quality of life of residents. Fairfax County offers businesses a state-of-the-art telecommunications infrastructure, access to global markets through Washington Dulles International Airport, a vibrant investment capital community and a highly skilled, well-educated workforce.

The award-winning Fairfax County Economic Development Authority promotes Fairfax County as a business and technology center. The FCEDA offers site location and business development assistance, and connections with county and state government agencies, to help companies locate and expand in Fairfax County. In addition to its headquarters in Tysons Corner, Fairfax County’s largest business district, the FCEDA maintains marketing offices in six important global business centers: Bangalore, Berlin, London, Los Angeles, Seoul and Tel Aviv. Follow the FCEDA on Facebook, Twitter, LinkedIn.

View source version on businesswire.com: http://www.businesswire.com/news/home/20170522005477/en/

CONTACT

FCEDA
Alan Fogg, +1 703-790-0600 (office)
571-213-5065 (mobile)
afogg@fceda.org
or
Granules
India
Priyanka Chigurupati, +1 973-906-1731
pchigurupati@granulesindia.com

同じカテゴリーの記事 

  • 冠科生物连续三年荣膺T+ Employer® 卓越雇主
  • Crown Bioscienceが3年連続でT+ Employer®に認定される
  • Better Foods of Shinsegae Food Participates in NPEW to Accelerate Entry to U.S. Plant-based Food Market
  • GRAIL Announces Novel Risk Classification Test to Be Used in Lung Cancer Study
  • Otsuka and Lundbeck Present New Data Analyses on the Efficacy of REXULTI® (brexpiprazole) for Agitation Associated with Dementia Due to Alzheimer’s Disease